Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation

Neuropsychopharmacology

Volumn 35, Issue 3, 2010, Pages 702-719

  Wang, Ju ^a   Li, Ming D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Nicotine dependence; Pathway analysis; Smoking cessation; Smoking initiation

Indexed keywords

CALCIUM; CYCLIC AMP; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; NEUROTROPHIN; PROTEIN TYROSINE KINASE; SEROTONIN RECEPTOR;

ARTICLE; BRAIN FUNCTION; BRAIN NERVE CELL; CALCIUM SIGNALING; GAP JUNCTION; GENE IDENTIFICATION; HUMAN; LONG TERM POTENTIATION; PHENOTYPE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TIGHT JUNCTION; TOBACCO DEPENDENCE; TRYPTOPHAN METABOLISM;

DATABASES, GENETIC; DISEASE PROGRESSION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; SIGNAL TRANSDUCTION; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 75749124555     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2009.178     Document Type: Article

References (174)

1. Agrawal A, Pergadia ML, Saccone SF, Hinrichs AL, Lessov-Schlaggar CN, Saccone NL et al (2008). Gamma-aminobutyric acid receptor genes and nicotine dependence: evidence for association from a case-control study. Addiction 103: 1027-1038.
2. Anney RJ, Lotfi-Miri M, Olsson CA, Reid SC, Hemphill SA, Patton GC (2007). Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults. BMC Genet 8: 46.
3. Audrain-McGovern J, Al Koudsi N, Rodriguez D, Wileyto EP, Shields PG, Tyndale RF (2007). The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 119: e264-e274.
4. Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG (2004). Interacting effects of genetic predisposition and depression on adolescent smoking progression. Am J Psychiatry 161: 1224-1230.
5. Benjamini Y, Hochberg Y (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 57: 289-300.
6. Berrettini W, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H et al (2008). Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13: 368-373.
7. Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P et al (2007). Catechol-O-methyltransferase (COMT) gene variants predict response to bupropion therapy for tobacco dependence. Biol Psychiatry 61: 111-118.
8. Beuten J, Ma JZ, Lou XY, Payne TJ, Li MD (2007a). Association analysis of the protein phosphatase 1 regulatory subunit 1B (PPP1R1B) gene with nicotine dependence in European-and African-American smokers. Am J Med Genet B Neuropsychiatr Genet 144B: 285-290.
9. Beuten J, Ma JZ, Payne TJ, Dupont RT, Crews KM, Somes G et al (2005a). Single-and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. Am J Hum Genet 76: 859-864.
10. Beuten J, Ma JZ, Payne TJ, Dupont RT, Lou XY, Crews KM et al (2007b). Association of specific haplotypes of neurotrophic tyrosine kinase receptor 2 gene (NTRK2) with vulnerability to nicotine dependence in African-Americans and European-Americans. Biol Psychiatry 61: 48-55.
11. Beuten J, Ma JZ, Payne TJ, Dupont RT, Quezada P, Huang W et al (2005b). Significant association of BDNF haplotypes in European-American male smokers but not in European-American female or African-American smokers. Am J Med Genet B Neuropsychiatr Genet 139B: 73-80.
12. Beuten J, Payne TJ, Ma JZ, Li MD (2006). Significant association of catechol-O-methyltransferase (COMT) haplotypes with nicotine dependence in male and female smokers of two ethnic populations. Neuropsychopharmacology 31: 675-684.
13. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF et al (2007). Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16: 24-35.
14. Brody CL, Hamer DH, Haaga DA (2005). Depression vulnerability, cigarette smoking, and the serotonin transporter gene. Addict Behav 30: 557-566.
15. Burgoyne RD (2007). Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci 8: 182-193.
16. Cannon DS, Baker TB, Piper ME, Scholand MB, Lawrence DL, Drayna DT et al (2005). Associations between phenylthiocarba-mide gene polymorphisms and cigarette smoking. Nicotine Tob Res 7: 853-858.
17. Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, Issaq HJ et al (2001). Nicotine metabolism and CYP2D6 phenotype in smokers. Cancer Epidemiol Biomarkers Prev 10: 261-263.
18. Carlezon Jr WA, Duman RS, Nestler EJ (2005). The many faces of CREB. Trends Neurosci 28: 436-445.
19. CDC (2005a). Tobacco use, access, and exposure to tobacco in media among middle and high school studentsFUnited States, 2004. Morbid Mortal Wkly Rep 54: 297-301.
20. CDC (2005b). Annual smoking-attributable mortality, years of potential life lost, and economic costsFUnited States, 1997-2001. Morbid Mortal Wkly Rep 54: 625-628.
21. CDC (2006). Cigarette use among high school studentsFUnited States, 1991-2005
22. Morbid Mortal Wkly Rep 55: 724-726.
23. CDC (2007). Cigarette smoking among adultsFUnited States, 2006. Morbid Mortal Wkly Rep 56: 1157-1161.
24. Chen X, Che Y, Zhang L, Putman AH, Damaj I, Martin BR et al (2007). RhoA, encoding a Rho GTPase, is associated with smoking initiation. Genes Brain Behav 6: 689-697.
25. Chen X, Williamson VS, An SS, Hettema JM, Aggen SH, Neale MC et al (2008). Cannabinoid receptor 1 gene association with nicotine dependence. Arch Gen Psychiatry 65: 816-824.
26. Chen X, Wu B, Kendler KS (2004). Association study of the Epac gene and tobacco smoking and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 129B: 116-119.
27. Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J et al (2005). Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics 15: 393-398.
28. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D (1996). The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 6: 73-79.
29. Comings DE, Wu S, Gonzalez N, Iacono WG, McGue M, Peters WW et al (2001). Cholecystokinin (CCK) gene as a possible risk factor for smoking: a replication in two independent samples. Mol Genet Metab 73: 349-353.
30. Conti AC, Blendy JA (2004). Regulation of antidepressant activity by cAMP response element binding proteins. Mol Neurobiol 30: 143-155.
31. Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD et al (2008). Nicotinic acetylcholine receptor {beta}2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet 17: 2834-2848.
32. Costa-Mallen P, Costa LG, Checkoway H (2005). Genotype combinations for monoamine oxidase-B intron 13 polymorphism and dopamine D2 receptor TaqIB polymorphism are associated with ever-smoking status among men. Neurosci Lett 385: 158-162.
33. Dagda RK, Merrill RA, Cribbs JT, Chen Y, Hell JW, Usachev YM et al (2008). The spinocerebellar ataxia 12 gene product and protein phosphatase 2A regulatory subunit Bbeta2 antagonizes neuronal survival by promoting mitochondrial fission. J Biol Chem 283: 36241-36248.
34. Dagda RK, Zaucha JA, Wadzinski BE, Strack S (2003). A developmentally regulated, neuron-specific splice variant of the variable subunit Bbeta targets protein phosphatase 2A to mitochondria and modulates apoptosis. J Biol Chem 278: 24976-24985.
35. Dahl JP, Jepson C, Levenson R, Wileyto EP, Patterson F, Berrettini WH et al (2006). Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. Pharmacogenomics J 6: 194-199. (Pubitemid 43811571)
36. David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafo MR et al (2007a). Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine Tob Res 9: 821-833.
37. David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C et al (2008a). Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug Alcohol Depend 98: 77-85.
38. David SP, Munafo MR, Murphy MF, Proctor M, Walton RT, Johnstone EC (2008b). Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Phar-macogenomics J 8: 122-128.
39. David SP, Munafo MR, Murphy MF, Walton RT, Johnstone EC (2007b). The serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial. Nicotine Tob Res 9: 225-231.
40. De Luca V, Wong AH, Muller DJ, Wong GW, Tyndale RF, Kennedy JL (2004). Evidence of association between smoking and alpha7 nicotinic receptor subunit gene in schizophrenia patients. Neuropsychopharmacology 29: 1522-1526.
41. do Prado-Lima PA, Chatkin JM, Taufer M, Oliveira G, Silveira E, Neto CA et al (2004). Polymorphism of 5HT2A serotonin receptor gene is implicated in smoking addiction. Am J Med Genet B Neuropsychiatr Genet 128B: 90-93.
42. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C et al (2007). A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545.
43. Dudman JT, Eaton ME, Rajadhyaksha A, Macias W, Taher M, Barczak A et al (2003). Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 87: 922-934.
44. Ehringer MA, Clegg HV, Collins AC, Corley RP, Crowley T, Hewitt JK et al (2007). Association of the neuronal nicotinic receptor beta2 subunit gene (CHRNB2) with subjective responses to alcohol and nicotine. Am J Med Genet B Neuropsychiatr Genet 144B: 596-604.
45. Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH (2005). Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. Mol Psychiatry 10: 407-414.
46. Feng Y, Niu T, Xing H, Xu X, Chen C, Peng S et al (2004). A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. Am J Hum Genet 75: 112-121.
47. Fletcher PJ, Le AD, Higgins GA (2008). Serotonin receptors as potential targets for modulation of nicotine use and dependence. Prog Brain Res 172: 361-383.
48. Gambier N, Batt AM, Marie B, Pfister M, Siest G, Visvikis-Siest S (2005). Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort. Pharmacogenomics J 5: 271-275.
49. Gelernter J, Panhuysen C, Weiss R, Brady K, Poling J, Krauthammer M et al (2007). Genomewide linkage scan for nicotine dependence: identification of a chromosome 5 risk locus. Biol Psychiatry 61: 119-126.
50. Gelernter J, Yu Y, Weiss R, Brady K, Panhuysen C, Yang BZ et al (2006). Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum Mol Genet 15: 3498-3507.
51. Gerra G, Garofano L, Zaimovic A, Moi G, Branchi B, Bussandri M et al (2005). Association of the serotonin transporter promoter polymorphism with smoking behavior among adolescents. Am J Med Genet B Neuropsychiatr Genet 135B: 73-78.
52. Goode EL, Badzioch MD, Kim H, Gagnon F, Rozek LS, Edwards KL et al (2003). Multiple genome-wide analyses of smoking behavior in the Framingham Heart Study. BMC Genet 4(Suppl 1): S102.
53. Guo S, Chen da F, Zhou DF, Sun HQ, Wu GY, Haile CN et al (2007). Association of functional catechol-O-methyl transferase (COMT) Val108Met polymorphism with smoking severity and age of smoking initiation in Chinese male smokers. Psycho-pharmacology (Berl) 190: 449-456.
54. Hall W, Madden P, Lynskey M (2002). The genetics of tobacco use: methods, findings and policy implications. Tob Control 11: 119-124.
55. Hamilton AS, Lessov-Schlaggar CN, Cockburn MG, Unger JB, Cozen W, Mack TM (2006). Gender differences in determinants of smoking initiation and persistence in California twins. Cancer Epidemiol Biomarkers Prev 15: 1189-1197.
56. Han DH, Joe KH, Na C, Lee YS (2008). Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers. Psychiatr Genet 18: 11-16.
57. Hardie TL, Moss HB, Lynch KG (2006). Genetic correlations between smoking initiation and smoking behaviors in a twin sample. Addict Behav 31: 2030-2037.
58. Heath AC, Kirk KM, Meyer JM, Martin NG (1999). Genetic and social determinants of initiation and age at onset of smoking in Australian twins. Behav Genet 29: 395-407.
59. Ho MK, Tyndale RF (2007). Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics J 7: 81-98.
60. Holmes SE, O'Hearn EE, McInnis MG, Gorelick-Feldman DA, Kleiderlein JJ, Callahan C et al (1999). Expansion of a novel CAG trinucleotide repeat in the 5 region of PPP2R2B is associated with SCA12. Nat Genet 23: 391-392.
61. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA (2003). Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
62. Howard LA, Ahluwalia JS, Lin SK, Sellers EM, Tyndale RF (2003). CYP2E1*1D regulatory polymorphism: association with alcohol and nicotine dependence. Pharmacogenetics 13: 321-328.
63. Huang da W, Sherman BT, Lempicki RA (2009). Systematic and integrative analysis of large gene lists using DAVID bioinfor-matics resources. Nat Protoc 4: 44-57.
64. Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD (2008a). Significant association of DRD1 with nicotine dependence. Hum Genet 123: 133-140.
65. Huang W, Payne TJ, Ma JZ, Beuten J, Dupont RT, Inohara N et al (2009). Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American sample. Neuropsychopharmacology 34: 319-330.
66. Huang W, Payne TJ, Ma JZ, Li MD (2008b). A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers. Am J Med Genet B Neuropsychiatr Genet 147B: 1109-1115.
67. Hubacek J, Pitha J, Skodova Z, Poledne R (2002). Is the CD14 receptor gene a marker for smoking dependence? Med Sci Monit 8: BR172-BR174.
68. Hughes JR, Stead LF, Lancaster T (2007). Antidepressants for smoking cessation. Cochrane Database Syst Rev Issue 1. Art. No. CD000031.
69. Ito H, Matsuo K, Hamajima N, Okuma K, Saito T, Tajima K (2005). Significant association of interleukin 8-251T/A polymorphism with smoking behavior in a Japanese population. J Hum Genet 50: 567-573.
70. Johnstone EC, Elliot KM, David SP, Murphy MF, Walton RT, Munafo MR (2007). Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev 16: 1065-1069.
71. Johnstone EC, Yudkin PL, Hey K, Roberts SJ, Welch SJ, Murphy MF et al (2004). Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics 14: 83-90.
72. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R (2002). Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 22: 8476-8486.
73. Kauer JA (2004). Learning mechanisms in addiction: synaptic plasticity in the ventral tegmental area as a result of exposure to drugs of abuse. Annu Rev Physiol 66: 447-475.
74. Keller A, Backes C, Al-Awadhi M, Gerasch A, Kuntzer J, Kohlbacher O et al (2008). GeneTrail Express: a web-based pipeline for the statistical evaluation of microarray experiments. BMC Bioinformatics 9: 552.
75. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA (1999). A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 29: 299-308.
76. Kremer I, Bachner-Melman R, Reshef A, Broude L, Nemanov L, Gritsenko I et al (2005). Association of the serotonin transporter gene with smoking behavior. Am J Psychiatry 162: 924-930.
77. Kubota T, Nakajima-Taniguchi C, Fukuda T, Funamoto M, Maeda M, Tange E et al (2006). CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation. Pharmacogenomics J 6: 115-119.
78. Lang UE, Sander T, Lohoff FW, Hellweg R, Bajbouj M, Winterer G et al (2007). Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) 190: 433-439.
79. Laucht M, Becker K, Frank J, Schmidt MH, Esser G, Treutlein J et al (2008). Genetic variation in dopamine pathways differentially associated with smoking progression in adolescence. J Am Acad Child Adolesc Psychiatry 47: 673-681.
80. Lee AM, Jepson C, Hoffmann E, Epstein L, Hawk LW, Lerman C et al (2007). CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biol Psychiatry 62: 635-641.
81. Lerer E, Kanyas K, Karni O, Ebstein RP, Lerer B (2006). Why do young women smoke? II. Role of traumatic life experience, psychological characteristics and serotonergic genes. Mol Psychiatry 11: 771-781.
82. Lerman C, Berrettini W (2003). Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 118B: 48-54.
83. Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B et al (1999). Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 18: 14-20.
84. Lerman C, Caporaso NE, Bush A, Zheng YL, Audrain J, Main D et al (2001). Tryptophan hydroxylase gene variant and smoking behavior. Am J Med Genet 105: 518-520.
85. Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F et al (2006). Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 31: 231-242.
86. Lerman C, Shields PG, Audrain J, Main D, Cobb B, Boyd NR et al (1998). The role of the serotonin transporter gene in cigarette smoking. Cancer Epidemiol Biomarkers Prev 7: 253-255.
87. Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S et al (2004). The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J 4: 184-192.
88. Lerman CE, Schnoll RA, Munafo MR (2007). Genetics and smoking cessation improving outcomes in smokers at risk. Am J Prev Med 33(6 Suppl): S398-S405.
89. Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE (2008). Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol 75: 178-195.
90. Lessov CN, Martin NG, Statham DJ, Todorov AA, Slutske WS, Bucholz KK et al (2004a). Defining nicotine dependence for genetic research: evidence from Australian twins. Psychol Med 34: 865-879.
91. Lessov CN, Swan GE, Ring HZ, Khroyan TV, Lerman C (2004b). Genetics and drug use as a complex phenotype. Subst Use Misuse 39: 1515-1569.
92. Lewis A, Miller JH, Lea RA (2007). Monoamine oxidase and tobacco dependence. Neurotoxicology 28: 182-195.
93. Li CY, Mao X, Wei L (2008). Genes and (common) pathways underlying drug addiction. PLoS Comput Biol 4: e2.
94. Li MD, Beuten J, Ma JZ, Payne TJ, Lou XY, Garcia V et al (2005). Ethnic-and gender-specific association of the nicotinic acet-ylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum Mol Genet 14: 1211-1219.
95. Li MD, Cheng R, Ma JZ, Swan GE (2003). A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 98: 23-31.
96. Li MD, Sun D, Lou XY, Beuten J, Payne TJ, Ma JZ (2007). Linkage and association studies in African-and Caucasian-American populations demonstrate that SHC3 is a novel susceptibility locus for nicotine dependence. Mol Psychiatry 12: 462-473.
97. Ling D, Niu T, Feng Y, Xing H, Xu X (2004). Association between polymorphism of the dopamine transporter gene and early smoking onset: an interaction risk on nicotine dependence. J Hum Genet 49: 35-39.
98. Liu Y, Yoshimura K, Hanaoka T, Ohnami S, Ohnami S, Kohno T et al (2005). Association of habitual smoking and drinking with single nucleotide polymorphism (SNP) in 40 candidate genes: data from random population-based Japanese samples. J Hum Genet 50: 62-68.
99. Lou XY, Ma JZ, Payne TJ, Beuten J, Crew KM, Li MD (2006). Gene-based analysis suggests association of the nicotinic acetylcholine receptor beta1 subunit (CHRNB1) and M1 muscarinic acetylcho-line receptor (CHRM1) with vulnerability for nicotine dependence. Hum Genet 120: 381-389.
100. Lou XY, Ma JZ, Sun D, Payne TJ, Li MD (2007). Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. Hum Mol Genet 16: 142-153.
101. Ma JZ, Beuten J, Payne TJ, Dupont RT, Elston RC, Li MD (2005). Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum Mol Genet 14: 1691-1698.
102. Maes HH, Sullivan PF, Bulik CM, Neale MC, Prescott CA, Eaves LJ et al (2004). A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med 34: 1251-1261.
103. Malaiyandi V, Sellers EM, Tyndale RF (2005). Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence. Clin Pharmacol Ther 77: 145-158.
104. Mangold JE, Payne TJ, Ma JZ, Chen G, Li MD (2008). Bitter taste receptor gene polymorphisms are an important factor in the development of nicotine dependence in African Americans. J Med Genet 45: 578-582.
105. Marshall DL, Redfern PH, Wonnacott S (1997). Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 68: 1511-1519.
106. Mayhew KP, Flay BR, Mott JA (2000). Stages in the development of adolescent smoking. Drug Alcohol Depend 59(Suppl 1): S61-S81.
107. McKinney EF, Walton RT, Yudkin P, Fuller A, Haldar NA, Mant D et al (2000). Association between polymorphisms in dopamine metabolic enzymes and tobacco consumption in smokers. Pharmacogenetics 10: 483-491.
108. Minematsu N, Nakamura H, Furuuchi M, Nakajima T, Takahashi S, Tateno H et al (2006). Limitation of cigarette consumption by CYP2A6*4, *7 and *9 polymorphisms. Eur Respir J 27: 289-292.
109. Morley KI, Lynskey MT, Madden PA, Treloar SA, Heath AC, Martin NG (2007). Exploring the inter-relationship of smoking age-at-onset, cigarette consumption and smoking persistence: genes or environment? Psychol Med 37: 1357-1367.
110. Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R et al (2006). DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet Genomics 16: 901-910.
111. Munafo MR, Elliot KM, Murphy MF, Walton RT, Johnstone EC (2007). Association of the mu-opioid receptor gene with smoking cessation. Pharmacogenomics J 7: 353-361.
112. Munafo MR, Johnstone EC (2008). Genes and cigarette smoking. Addiction 103: 893-904.
113. Munafo MR, Johnstone EC, Wileyto EP, Shields PG, Elliot KM, Lerman C (2006). Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiol Biomarkers Prev 15: 398-400.
114. Murray S (2006). A smouldering epidemic. CMAJ 174: 309-310.
115. Nestler EJ (2005). Is there a common molecular pathway for addiction? Nat Neurosci 8: 1445-1449.
116. Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ et al (1994). D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses 42: 257-260.
117. Nussbaum J, Xu Q, Payne TJ, Ma JZ, Huang W, Gelernter J et al (2008). Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European-and African-American smokers. Hum Mol Genet 17: 1569-1577.
118. O'Gara C, Knight J, Stapleton J, Luty J, Neale B, Nash M et al (2008). Association of the serotonin transporter gene, neuroti-cism and smoking behaviours. J Hum Genet 53: 239-246.
119. O'Gara C, Stapleton J, Sutherland G, Guindalini C, Neale B, Breen G et al (2007). Dopamine transporter polymorphisms are associated with short-term response to smoking cessation treatment. Pharmacogenet Genomics 17: 61-67.
120. Olsson C, Anney R, Forrest S, Patton G, Coffey C, Cameron T et al (2004). Association between dependent smoking and a polymorphism in the tyrosine hydroxylase gene in a prospective population-based study of adolescent health. Behav Genet 34: 85-91.
121. Osler M, Holst C, Prescott E, Sorensen TI (2001). Influence of genes and family environment on adult smoking behavior assessed in an adoption study. Genet Epidemiol 21: 193-200.
122. Ozaki S, Oyama T, Isse T, Kagawa N, Uramoto H, Sugio K et al (2006). Smoking cessation program and CYP2A6 polymorphism. Front Biosci 11: 2590-2597.
123. Park HJ, Kim ST, Yoon DH, Jin SH, Lee SJ, Lee HJ et al (2005). The association between the DRD2 TaqI A polymorphism and smoking cessation in response to acupuncture in Koreans. J Altern Complement Med 11: 401-405.
124. Pomerleau OF, Pomerleau CS, Chu J, Kardia SL (2007). Genome-wide linkage analysis for smoking-related regions, with replication in two ethnically diverse populations. Nicotine Tob Res 9: 955-958.
125. Prestes AP, Marques FZ, Hutz MH, Roman T, Bau CH (2007). Tobacco smoking and the ADRA2A C-1291G polymorphism. J Neural Transm 114: 1503-1506.
126. Radwan GN, El-Setouhy M, Mohamed MK, Hamid MA, Azem SA, Kamel O et al (2007). DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers. Nicotine Tob Res 9: 1325-1329.
127. Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K et al (2006). Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology (Berl) 188: 355-363.
128. Ray R, Jepson C, Wileyto EP, Dahl JP, Patterson F, Rukstalis M et al (2007a). Genetic variation in mu-opioid-receptor-interact-ing proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine Tob Res 9: 1237-1241.
129. Ray R, Jepson C, Wileyto P, Patterson F, Strasser AA, Rukstalis M et al (2007b). CREB1 haplotypes and the relative reinforcing value of nicotine. Mol Psychiatry 12: 615-617.
130. Reuter M, Hennig J (2005). Pleiotropic effect of the TPH A779C polymorphism on nicotine dependence and personality. Am J Med Genet B Neuropsychiatr Genet 134B: 20-24.
131. Reuter M, Hennig J, Amelang M, Montag C, Korkut T, Hueweler A et al (2007). The role of the TPH1 and TPH2 genes for nicotine dependence: a genetic association study in two different age cohorts. Neuropsychobiology 56: 47-54.
132. Robinson JD, Lam CY, Minnix JA, Wetter DW, Tomlinson GE, Minna JD et al (2007). The DRD2 TaqI-B polymorphism and its relationship to smoking abstinence and withdrawal symptoms. Pharmacogenomics J 7: 266-274.
133. Rogausch A, Kochen MM, Meineke C, Hennig J (2007). Association between the BclI glucocorticoid receptor polymorphism and smoking in a sample of patients with obstructive airway disease. Addict Biol 12: 93-99.
134. Saal D, Dong Y, Bonci A, Malenka RC (2003). Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37: 577-582.
135. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA et al (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16: 36-49
136. SAMHSA (2006). Results from the 2005 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-30, DHHS Publication No. SMA 06-4194.
137. DHHS: Rockville, MD. Schlaepfer IR, Hoft NR, Collins AC, Corley RP, Hewitt JK, Hopfer CJ et al (2008). The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 63: 1039-1046.
138. Schmidt K, Kins S, Schild A, Nitsch RM, Hemmings BA, Gotz J (2002). Diversity, developmental regulation and distribution of murine PR55/B subunits of protein phosphatase 2A. Eur J Neurosci 16: 2039-2048.
139. Schwab SG, Franke PE, Hoefgen B, Guttenthaler V, Lichtermann D, Trixler M et al (2005). Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence. Neuropsychopharmacology 30: 2263-2268.
140. Segman RH, Kanyas K, Karni O, Lerer E, Goltser-Dubner T, Pavlov V et al (2007). Why do young women smoke? IV. Role of genetic variation in the dopamine transporter and lifetime traumatic experience. Am J Med Genet B Neuropsychiatr Genet 144B: 533-540.
141. Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR et al (1998). Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 7: 453-458.
142. Skowronek MH, Laucht M, Hohm E, Becker K, Schmidt MH (2006). Interaction between the dopamine D4 receptor and the serotonin transporter promoter polymorphisms in alcohol and tobacco use among 15-year-olds. Neurogenetics 7: 239-246.
143. Smith SS, Fiore MC (1999). The epidemiology of tobacco use, dependence, and cessation in the United States. Prim Care 26: 433-461.
144. Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM et al (1998). Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 90: 358-363.
145. Stapleton JA, Sutherland G, O'Gara C (2007). Association between dopamine transporter genotypes and smoking cessation: a meta-analysis. Addict Biol 12: 221-226. (Pubitemid 46753645)
146. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA et al (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
147. Sullivan PF, Jiang Y, Neale MC, Kendler KS, Straub RE (2001). Association of the tryptophan hydroxylase gene with smoking initiation but not progression to nicotine dependence. Am J Med Genet 105: 479-484.
148. Sullivan PF, Kendler KS (1999). The genetic epidemiology of smoking. Nicotine Tob Res 1(Suppl 2): S51-S57; discussion S69-70.
149. Sullivan PF, Neale BM, van den Oord E, Miles MF, Neale MC, Bulik CM et al (2004). Candidate genes for nicotine dependence via linkage, epistasis, and bioinformatics. Am J Med Genet B Neuropsychiatr Genet 126B: 23-36.
150. Sun D, Ma JZ, Payne TJ, Li MD (2008). Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. Mol Psychiatry 13: 398-406.
151. Swan GE, Valdes AM, Ring HZ, Khroyan TV, Jack LM, Ton CC et al (2005). Dopamine receptor DRD2 genotype and smoking cessation outcome following treatment with bupropion SR. Pharmacogenomics J 5: 21-29.
152. Takimoto T, Terayama H, Waga C, Okayama T, Ikeda K, Fukunishi I et al (2005). Cholecystokinin (CCK) and the CCKA receptor gene polymorphism, and smoking behavior. Psychiatry Res 133: 123-128.
153. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, Kim JS et al (2009). A novel signaling pathway impact analysis. Bioinfor-matics 25: 75-82.
154. Thomas MJ, Malenka RC (2003). Synaptic plasticity in the mesolimbic dopamine system. Philos Trans R Soc Lond B Biol Sci 358: 815-819.
155. Timberlake DS, Haberstick BC, Lessem JM, Smolen A, Ehringer M, Hewitt JK et al (2006). An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. Health Psychol 25: 190-197.
156. Tochigi M, Suzuki K, Kato C, Otowa T, Hibino H, Umekage T et al (2007). Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior. Pharmaco-genet Genomics 17: 867-872.
157. True WR, Xian H, Scherrer JF, Madden PA, Bucholz KK, Heath AC et al (1999). Common genetic vulnerability for nicotine and alcohol dependence in men. Arch Gen Psychiatry 56: 655-661.
158. Tyndale RF (2003). Genetics of alcohol and tobacco use in humans. Ann Med 35: 94-121.
159. Tyndale RF, Pianezza ML, Sellers EM (1999). A common genetic defect in nicotine metabolism decreases risk for dependence and lowers cigarette consumption. Nicotine Tob Res 1(Suppl 2): S63-S67; discussion S69-70.
160. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE (2007). Molecular genetics of nicotine dependence and abstinence: whole genome association using 520,000 SNPs. BMC Genet 8: 10.
161. Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE et al (2008).
162. Vandenbergh DJ, O'Connor RJ, Grant MD, Jefferson AL, Vogler GP, Strasser AA et al (2007). Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors. Addict Biol 12: 106-116.
163. Vink JM, Beem AL, Posthuma D, Neale MC, Willemsen G, Kendler KS et al (2004). Linkage analysis of smoking initiation and quantity in Dutch sibling pairs. Pharmacogenomics J 4: 274-282.
164. Vink JM, Smit AB, de Geus EJ, Sullivan P, Willemsen G, Hottenga JJ et al (2009). Genome-wide association study of smoking initiation and current smoking. Am J Hum Genet 84: 367-379.
165. Wonnacott S (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci 20: 92-98.
166. Xian H, Scherrer JF, Madden PA, Lyons MJ, Tsuang M, True WR et al (2003). The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob Res 5: 245-254.
167. Xu Q, Huang W, Payne TJ, Ma JZ, Li MD (2009). Detection of genetic association and a functional polymorphism of dynamin 1 gene with nicotine dependence in European and African Americans. Neuropsychopharmacology 34: 1351-1359.
168. Yu JH, Bigler J, Whitton J, Potter JD, Ulrich CM (2006a). Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G4A variant modifies risk associated with smoking. Am J Gastro-enterol 101: 1313-1319.
169. Yu Y, Panhuysen C, Kranzler HR, Hesselbrock V, Rounsaville B, Weiss R et al (2006b). Intronic variants in the dopa decarbox-ylase (DDC) gene are associated with smoking behavior in European-Americans and African-Americans. Hum Mol Genet 15: 2192-2199.
170. Yudkin P, Munafo M, Hey K, Roberts S, Welch S, Johnstone E et al (2004). Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial. BMJ 328: 989-990.
171. Zeiger JS, Haberstick BC, Schlaepfer I, Collins AC, Corley RP, Crowley TJ et al (2008). The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Hum Mol Genet 17: 724-734.
172. Zhang H, Ye Y, Wang X, Gelernter J, Ma JZ, Li MD (2006a). DOPA decarboxylase gene is associated with nicotine dependence. Pharmacogenomics 7: 1159-1166.
173. Zhang L, Kendler KS, Chen X (2006b). Association of the phosphatase and tensin homolog gene (PTEN) with smoking initiation and nicotine dependence. Am J Med Genet B Neuropsychiatr Genet 141B: 10-14.
174. Zhang L, Kendler KS, Chen X (2006c). The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav Brain Funct 2: 28.